{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-pneumococcal/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"197178ce-11cd-52df-883c-419e06744dd4","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 2fb37b67-0821-4dbe-8ff9-901a4e67ad20 --><h2>Update</h2><!-- end field 2fb37b67-0821-4dbe-8ff9-901a4e67ad20 -->","summary":null,"htmlStringContent":"<!-- begin item 43649ed0-bb51-47f4-83bf-322e0101050e --><!-- end item 43649ed0-bb51-47f4-83bf-322e0101050e -->","topic":{"id":"af89c4a4-b7c5-5032-9cab-157c542f213b","topicId":"667146c4-e374-494f-a050-b8976e5e7056","topicName":"Immunizations - pneumococcal","slug":"immunizations-pneumococcal","lastRevised":"Last revised in January 2021","chapters":[{"id":"c2a8d969-5d35-5185-b666-883786b066c5","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9db009c1-59ed-5d79-9446-33e54e1676c7","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"cf4adec7-88ef-5a0f-b072-53bd3049b260","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5459dd7c-ac40-5828-8bec-840fa7fca764","slug":"changes","fullItemName":"Changes"},{"id":"197178ce-11cd-52df-883c-419e06744dd4","slug":"update","fullItemName":"Update"}]},{"id":"95a44f6b-2987-5086-8656-ef21fcbbc28b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"006db835-5d01-5085-a6e1-ee57f7ca41c8","slug":"goals","fullItemName":"Goals"},{"id":"29af8dc8-13e9-56c4-a041-b00bbf320b1e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e7b32647-3434-5f3f-b8be-51203e3ebfee","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ebc71bdc-4766-5946-bb16-121b9da544f3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3daf6a12-bce0-53d4-a318-05cc49aab107","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4dce4bc5-1119-5c5d-9422-d275fc956a4e","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"002fbb60-3041-597d-9d3d-fc3a17068591","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"37c59838-49d0-51d5-8203-1eae848738c2","slug":"definition-of-pneumococcal-disease","fullItemName":"Definition of pneumococcal disease"},{"id":"aba9a3c5-f0f7-5e65-b369-1947461d0158","slug":"prevalence-of-pneumococcal-disease","fullItemName":"Prevalence of pneumococcal disease"},{"id":"9da9e662-ccc4-5bc4-bae8-eb3f0ec80b19","slug":"risk-factors-for-pneumococcal-disease","fullItemName":"Risk Factors for pneumococcal disease"},{"id":"492f20c5-5e03-51dc-9ccb-1994f3db1c35","slug":"pneumococcal-immunization","fullItemName":"Pneumococcal immunization"}]},{"id":"e183f01f-d538-542b-bc16-6f849966d1d2","fullItemName":"Management","slug":"management","subChapters":[{"id":"b036915e-0e64-5fea-a247-9777822304b3","slug":"routine-vaccination-of-infants-adults-over-65-years-of-age","fullItemName":"Scenario: Routine vaccination of infants, and adults over 65 years of age"},{"id":"8f83b7e0-d764-5bca-a03b-e549e24f402a","slug":"children-diagnosed-at-increased-risk-under-2-years-of-age","fullItemName":"Scenario: Children diagnosed at increased risk under 2 years of age"},{"id":"c9787edf-835f-54d9-9b86-b7c8695307ef","slug":"children-diagnosed-at-increased-risk-aged-2-5-years","fullItemName":"Scenario: Children diagnosed at increased risk aged 2-5 years"},{"id":"7f443a07-5081-5296-b56e-8b82550f8c52","slug":"children-over-5-years-of-age-adults-diagnosed-at-increased-risk","fullItemName":"Scenario: Children over 5 years of age and adults diagnosed at increased risk"}]},{"id":"f17e101b-7bea-59aa-9b9c-46924bbfdc2b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"871f5861-588e-57ef-9521-0a81e77d4583","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d0a50959-6448-5a18-8845-f75f5c40f388","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"92b33782-e97b-565d-b432-b19376ecedbc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5b1e27f9-71f0-5238-978b-5648b601e292","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2b6c5d09-7606-5742-89c4-19fa3b671fd7","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"037af05f-e510-5862-b316-4676f7c3a61e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"04bd9328-ed11-5b9d-ba9a-06584ecd6f33","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"cf4adec7-88ef-5a0f-b072-53bd3049b260","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"32b07604-9106-5f9a-a9db-6875684812c4","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 11c4ac5c-4905-4be3-bd18-51aa21b118c2 --><h3>New evidence</h3><!-- end field 11c4ac5c-4905-4be3-bd18-51aa21b118c2 -->","summary":null,"htmlStringContent":"<!-- begin item 06b1745e-b37f-44e2-b14f-4769f822d1ed --><!-- begin field 3b866197-3341-4515-b51e-479be0defbf1 --><h3>Evidence-based guidelines</h3><!-- end field 3b866197-3341-4515-b51e-479be0defbf1 --><!-- begin field e25082b0-c154-41d9-854d-01b723cfd234 --><p>The latest Vaccine update from Public Health England can be found here: <a href=\"https://www.gov.uk/government/collections/vaccine-update\" data-hyperlink-id=\"7e42ee75-4c14-45f0-a925-a97000d96179\">https://www.gov.uk/government/collections/vaccine-update</a>.</p><ul><li>PHE (2017) <em>Contraindications and special considerations: the green book, chapter 6.</em> Public Health England. <a href=\"http://www.gov.uk/\" data-hyperlink-id=\"ef1ae930-511d-4e6b-b3a0-a97000d961e9\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/contraindications-and-special-considerations-the-green-book-chapter-6\" data-hyperlink-id=\"fafc6104-361f-4778-a660-a97000d961fe\">Free Full-text</a>].</li><li>PHE (2017) Pneumococcal: the green book, chapter 25. <a href=\"http://www.gov.uk/\" data-hyperlink-id=\"c7a71e4e-d786-481d-a53e-a97000d9620f\">www.gov.uk</a> [<a href=\"https://www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-25\" data-hyperlink-id=\"80ac2b42-40f6-4958-a2b7-a97000d96224\">Free Full-text</a>]</li><li>PHE (2018) <em>Vaccine update 286, September 2018.</em> Public Health England. <a href=\"https://www.gov.uk/\" data-hyperlink-id=\"bfcd5c02-a8e9-4006-9716-a97000d9626f\">www.gov.uk</a> [<a href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/744508/VU_286_september_2018.pdf\" data-hyperlink-id=\"cce133ee-3be4-4523-b323-a97000d9627b\">Free Full-text</a>]</li></ul><!-- end field e25082b0-c154-41d9-854d-01b723cfd234 --><!-- begin field 7bb3f045-654a-4afd-b36c-27fa3e959024 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 7bb3f045-654a-4afd-b36c-27fa3e959024 --><!-- begin field 5d331d33-db7b-41bc-bcf8-ad24ab949ec3 --><p>No new HTAs since 1 July 2016.</p><!-- end field 5d331d33-db7b-41bc-bcf8-ad24ab949ec3 --><!-- begin field 119fde66-6b1a-4590-99ce-098fca7ca79e --><h3>Economic appraisals</h3><!-- end field 119fde66-6b1a-4590-99ce-098fca7ca79e --><!-- begin field 39d831fc-2d9f-4fd3-a757-a5e060d75bf2 --><p>No new economic appraisals relevant to England since 1 July 2016.</p><!-- end field 39d831fc-2d9f-4fd3-a757-a5e060d75bf2 --><!-- begin field 10662ae6-9649-4675-92c1-e638cb178028 --><h3>Systematic reviews and meta-analyses</h3><!-- end field 10662ae6-9649-4675-92c1-e638cb178028 --><!-- begin field 97fbd5fc-89e4-4110-ac85-0da0c85b9c94 --><p>No new systematic reviews or meta-analyses since 1 July 2016.</p><!-- end field 97fbd5fc-89e4-4110-ac85-0da0c85b9c94 --><!-- begin field acb03f03-569e-4f87-a30f-b1d4a690c705 --><h3>Primary evidence</h3><!-- end field acb03f03-569e-4f87-a30f-b1d4a690c705 --><!-- begin field 9a1d4510-7bb7-4981-8c6c-ffeb8cd10b76 --><p>No new randomized controlled trials published in the major journals since 1 July 2016.</p><!-- end field 9a1d4510-7bb7-4981-8c6c-ffeb8cd10b76 --><!-- end item 06b1745e-b37f-44e2-b14f-4769f822d1ed -->","subChapters":[]},{"id":"8db9705e-afc2-56da-83a3-59e8c6f70245","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field f3a2ad01-bf79-4a1a-b71d-7a3776546522 --><h3>New policies</h3><!-- end field f3a2ad01-bf79-4a1a-b71d-7a3776546522 -->","summary":null,"htmlStringContent":"<!-- begin item 81dad975-af4d-4d26-b046-5a32ecdc8664 --><!-- begin field 5010bb68-b0a3-44a3-a4ae-2bc5503d4412 --><p>No new national policies or guidelines since 1 July 2016.</p><!-- end field 5010bb68-b0a3-44a3-a4ae-2bc5503d4412 --><!-- end item 81dad975-af4d-4d26-b046-5a32ecdc8664 -->","subChapters":[]},{"id":"40908123-59ab-5cf2-a690-acaa5288a6b9","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 80f8a95c-eb3c-4abf-9141-b2232e3d4a7f --><h3>New safety alerts</h3><!-- end field 80f8a95c-eb3c-4abf-9141-b2232e3d4a7f -->","summary":null,"htmlStringContent":"<!-- begin item f189bb39-2fde-4574-b23a-68acb0cf7fdb --><!-- begin field a2d923f3-2943-4626-9d91-41ba096d7ada --><p>No new safety alerts since 1 July 2016.</p><!-- end field a2d923f3-2943-4626-9d91-41ba096d7ada --><!-- end item f189bb39-2fde-4574-b23a-68acb0cf7fdb -->","subChapters":[]},{"id":"6de6b58d-b1c7-58b7-a3bc-c98ea2044dc9","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 548e3695-2137-4f3b-984d-db968c9e98ae --><h3>Changes in product availability</h3><!-- end field 548e3695-2137-4f3b-984d-db968c9e98ae -->","summary":null,"htmlStringContent":"<!-- begin item 66cb1556-bd39-4d01-b1ce-4e1264989775 --><!-- begin field ee0a1d76-e0ff-4717-a76d-027d2b5b4bb7 --><ul><li>Pneumovax 23 is licensed for active immunisation against pneumococcal disease in children aged from 2 years, adolescents and adults. See more <a href=\"https://www.medicines.org.uk/emc/product/9692/smpc\" data-hyperlink-id=\"bf61754c-dff9-4a52-bba5-a9b200a9a4ae\">here</a>. </li><li>MenQuadfi (meningococcal vaccine) is recommended for approval for prophylaxis against invasive meningococcal disease caused by <em>Neisseria meningitidis </em>serogroups A, C, W, and Y. See more <a href=\"https://www.ema.europa.eu/en/medicines/human/summaries-opinion/menquadfi\" data-hyperlink-id=\"3aa8f122-3d6f-4dd7-8999-ac3d00bdf673\">here</a>.</li></ul><!-- end field ee0a1d76-e0ff-4717-a76d-027d2b5b4bb7 --><!-- end item 66cb1556-bd39-4d01-b1ce-4e1264989775 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}